MetaCap

Milestone Pharmaceuticals Insider Trades

NASDAQ: MISTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.765+0.0529 (+7.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
13 · $1.18M
Shares bought / sold
0 / 523.08K
Net activity
Net selling $1.2 million

Milestone Pharmaceuticals insider activity

Over the last 12 months, Milestone Pharmaceuticals insiders reported 24 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $1.2 million worth of stock, for net insider selling of $1.2 million. The largest seller was Oliveto Joseph, with $555,680 in reported sales.

The most recent filing shows Oliveto Joseph (President and CEO) selling 36,500 shares at $2.26 on Apr 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MIST's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MIST insider transactions

Milestone Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Apr 16, 2026Oliveto JosephPresident and CEOSale36,500$82.49KForm 4
Jan 26, 2026Hasija AmitCFO & EVP of Corp. DevelopmentSale12,245$23.63KForm 4
Jan 26, 2026Hasija AmitCFO & EVP of Corp. DevelopmentOption exercise20,100—Form 4
Jan 26, 2026Muller LorenzChief Commercial OfficerSale11,180$21.58KForm 4
Jan 26, 2026Muller LorenzChief Commercial OfficerOption exercise20,100—Form 4
Jan 26, 2026Oliveto JosephPresident and CEOSale34,523$66.63KForm 4
Jan 26, 2026Oliveto JosephPresident and CEOOption exercise66,600—Form 4
Jan 26, 2026Nelson Jeffrey EdwardChief Operating OfficerSale12,245$23.63KForm 4
Jan 26, 2026Nelson Jeffrey EdwardChief Operating OfficerOption exercise20,100—Form 4
Jan 26, 2026Bharucha DavidChief Medical OfficerSale12,245$23.63KForm 4
Jan 26, 2026Bharucha DavidChief Medical OfficerOption exercise20,100—Form 4
Jan 8, 2026Oliveto JosephPresident and CEOSale43,000$96.75KForm 4
Jan 7, 2026Oliveto JosephPresident and CEOSale500$1.13KForm 4
Dec 15, 2025Hasija AmitCFO & EVP of Corp. DevelopmentSale58,007$134.58KForm 4
Dec 15, 2025Muller LorenzChief Commercial OfficerSale53,566$124.27KForm 4
Dec 15, 2025Oliveto JosephPresident and CEOSale133,054$308.69KForm 4
Dec 15, 2025Nelson Jeffrey EdwardChief Operating OfficerSale58,007$134.58KForm 4
Dec 15, 2025Bharucha DavidChief Medical OfficerSale58,007$134.58KForm 4
Dec 12, 2025Hasija AmitCFO & EVP of Corp. DevelopmentAward100,000—Form 4
Dec 12, 2025Muller LorenzChief Commercial OfficerAward100,000—Form 4
Dec 12, 2025Oliveto JosephPresident and CEOAward280,000—Form 4
Dec 12, 2025Nelson Jeffrey EdwardChief Operating OfficerAward100,000—Form 4
Dec 12, 2025Bharucha DavidChief Medical OfficerAward100,000—Form 4
Dec 9, 2025Muller LorenzChief Commercial OfficerGift25,000—Form 4
Jul 11, 2025PAPA JOSEPH CDirectorAward100,000—Form 4
Jul 11, 2025Muller LorenzChief Commercial OfficerAward66,666—Form 4
Jul 11, 2025Oliveto JosephPresident and CEOAward66,666—Form 4
Jul 11, 2025Hasija AmitCFO & EVP of Corp. DevelopmentAward50,000—Form 4
Jul 11, 2025Liebert Debra K.DirectorAward16,666—Form 4
Jul 11, 2025Bharucha DavidChief Medical OfficerAward53,333—Form 4
Jul 11, 2025Wills Robert JamesDirectorAward50,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related